July 24, 2026

Integrating Environmental Health Into Pediatric Cancer Care May Improve Outcomes

A review of the scientific literature on the impact of environmental factors on the health of pediatric cancer survivors by Omar Shakeel, MD, Assistant Professor in the Department of Pediatrics, Divis...

The ASCO Post

July 24, 2026

Integrating Environmental Health Into Pediatric Cancer Care May Improve Outcomes

A review of the scientific literature on the impact of environmental factors on the health of pediatric cancer survivors by Omar Shakeel, MD, Assistant Professor in the Department of Pediatrics, Divis...

The ASCO Post

July 24, 2026

Bringing it Home: Why We Switched to In-House WGS

Annette Kim shares her experience of a real-world clinical laboratory transition to whole-genome sequencing

The Pathologist

July 15, 2026

Myopia Patterns in Intermittent Exotropia

New findings indicate intermittent exotropia may influence binocular ocular growth patterns without significantly increasing myopia risk

The Ophthalmologist

July 14, 2026

FDA Grants Traditional Approval to Selpercatinib for Locally Advanced or Metastatic RET Fusion–Positive Solid Tumors

Today, the FDA approved the oral RET inhibitor for adult and pediatric patients aged 2 years and older with locally advanced or metastatic solid tumors with a RET gene fusion, as detected by an FDA-ap...

The ASCO Post

July 09, 2026

Novel Gene Fusion Detector for Pediatric B-ALL Shows High Sensitivity

Researchers have developed a novel diagnostics tool to detect gene fusions in pediatric B-cell acute lymphoblastic leukemia (B-ALL) with greater sensitivity than standard detection algorithms, accordi...

The ASCO Post

July 09, 2026

Novel Gene Fusion Detector for Pediatric B-ALL Shows High Sensitivity

Researchers have developed a novel diagnostics tool to detect gene fusions in pediatric B-cell acute lymphoblastic leukemia (B-ALL) with greater sensitivity than standard detection algorithms, accordi...

The ASCO Post

July 02, 2026

FDA Expands Gene Therapy for Younger Patients

Exagamglogene autotemcel is now indicated for patients aged 2 years and older with sickle cell disease and recurrent vaso-occlusive crises or transfusion-dependent beta thalassemia.

MDSpire News

June 30, 2026

How Does Social Media Influence Health Decisions?

National survey findings suggest many US adults report making health decisions based on social media despite widespread concerns about the accuracy of health information shared to the platforms.

MDSpire News

June 26, 2026

FDA Monthly Preview: Key July Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

MDSpire News